The world health report

Chapter 2


Bibliography

  • Last JM, editor. A dictionary of epidemiology. New York: Oxford University Press;2001
  • Slovic P. Informing and educating the public about risk. Risk Analysis 1986; 6: 403-15.
  • Hope T. Journal of Medical Ethics. 2001; 3:179-85.
  • Murray CJL, Lopez AD. Quantifying the burden of disease and injury attributable to ten major risk factors. Murray CJL, Lopez AD, editors. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Cambridge (MA): Harvard University Press; 1996.
  • Murray CJL, Lopez AD. Global patterns of cause of death and burden of disease in 1990, with projections to 2020. Investing in health research and development. Report of the Ad Hoc Committee on Health Research Relating to Future Intervention Options 1996;
  • Peto R, Lopez AD, Boreham J, Thun M, Heath CW. Mortality from tobacco in developed countries: indirect estimates from national vital statistics. Lancet 1992; 339: 1268-78.
  • English DR, Holman CDJ, Milne E, Winter MG, Hulse GK, Codde JP, et al. The quantification of drug-caused morbidity and mortality in Australia, 1995. Canberra: Commonwealth Department of Human Services and Health; 1995.
  • Smith KR, Corvalan CF, Kjellstrom T. Epidemiology. 1999; 10:573-84.
  • Rodgers A, Lawes C, MacMahon S. The global burden of cardiovascular disease conferred by raised blood pressure. Journal of Hypertension 2000; 18 (Suppl):S3-S5.
  • Determinants of the burden of disease in the European Union. Sweden 1997. Stockholm: National Institute of Public Health Sweden; 1997.
  • Mathers C, Vos T, Stevenson C. The burden of disease and injury in Australia. Canberra: Australian Institute of Health and Welfare; 1999.
  • Our health, our future. The health of New Zealanders 1999. Wellington: Ministry of Health; 1999.
  • Murray CJL, Lopez AD, editors. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Cambridge (MA): Harvard University Press; 1996.
  • Cacioppo JT, Berntson GG, Sheridan JF, McClintock MK. Multi-level integrative analyses of human behavior. Psychological Bulletin 2000; 126: 829-43.
  • Ryff CD, Singer B. Biopsychosocial challenges of the new millennium. Psychotherapy and Psychosomatics 2000; 69((4)): 170-7.
  • Ryff CD, Singer B. The role of emotions on pathways to positive health. Davidson RJ, Goldsmith HH, Scherer K, editors. Handbook of affective science. New York: Oxford University Press; 2002.
  • Jessor R, Van Den, Vanderryn J, Costa FM, Turbin M. Protective factors in adolescent problem behaviours: moderator effects and developmental change. Developmental Psychology 1995; 31: 923-33.
  • Broadening the horizon: balancing protection and risk for adolescents. Geneva: World Health Organization; 2002.
  • Jessor R, Turbin MS, Costa FM. Risk and protection in successful outcomes among disadvantaged adolescents. Applied Developmental Science 1998; 2: 194-208.
  • Rose G. The strategy of preventive medicine. Oxford: Oxford University Press; 1992.
  • McMichael AJ, Beaglehole R. The changing global context of public health. Lancet 2000; 356: 495-99.
  • Winslow CEA. The cost of sickness and the price of health. Geneva: World Health Organization; 1951.
  • Barker DJP. Mothers, babies and disease in later life. 2nd ed. London: BMJ Publishing Group; 1998.
  • Ben-Shlomo Y, Kuh D. A life course approach to chronic disease epidemiology: conceptual models, empirical challenges and interdisciplinary perspectives. International Journal of Epidemiology 2002; 31:285-93.
  • Rose G. Sick individuals and sick populations. International Journal of Epidemiology 1985; 4: 32-8.
  • Rose G, Day S. The population mean predicts the number of deviant individuals. British Medical Journal 1990; 301: 1031-4.
  • Rothman KJ, Greenland S. Modern epidemiology. 2nd ed. Philadelphia: Lippincott-Raven Publishers; 1998.
  • Magnus P, Beaglehole R. The real contribution of the major risk factors to the coronary epidemics. Archives of Internal Medicine 2001; 161: 2657-60.
  • Hill AB. roceedings of the Royal Society of Medicine. 1965;58:295-300.
  • Murray CJL, Lopez AD, Mathers CD, Stein C. The Global Burden of Disease 2000 project: aims, methods and data sources.. Geneva: World Health Organization; 2001.
  • MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al. Blood pressure, stroke, and coronary heart disease. Lancet 1990; 335: 765-74.
  • Collins R, Peto R, MacMahon S, Hebert P. Fiebach NH, Eberlein KA, et al. Lancet 1990; 335: 827-38.
  • Law MR, Wald NJ, Thompson SG. British Medical Journal. 1994; 308:367-73.
  • Tobacco control country profiles. Atlanta (GA): American Cancer Society; 2000.
  • Robins JM. A new approach to causal inference in mortality studies with a sustained exposure period: applications to control of the healthy workers survivor effect. Mathematical Modeling 1986; 7: 1393-512.
  • Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837-47.
  • King G, Tomz M, Wittenberg J. Making the most of statistical analysis: improving interpretation and presentation. American Journal of Political Science 2000; 44: 341-55.
  • Rockhill B, Newman B, Weinberg C. Use and misuse of population attributable fractions. American Journal of Public Health 1998; 88: 15-9.